What is the recommended dosing of Levetiracetam (Keppra) in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levetiracetam (Keppra) Dosing in Children

The recommended dosing of levetiracetam in children is 10-20 mg/kg/day initially, increased every 2 weeks by 20 mg/kg/day increments to a target dose of 60 mg/kg/day divided into two doses. 1

Age-Specific Dosing Guidelines

Children 4 to <16 years (Partial Onset Seizures):

  • Initial dose: 20 mg/kg/day divided into two doses (10 mg/kg twice daily)
  • Titration: Increase by 20 mg/kg/day every 2 weeks
  • Target dose: 60 mg/kg/day (30 mg/kg twice daily)
  • Mean effective dose in clinical trials: 52 mg/kg/day 1

Children 6 to <16 years (Primary Generalized Tonic-Clonic Seizures):

  • Same dosing as for partial onset seizures
  • Effectiveness of doses lower than 60 mg/kg/day has not been adequately studied 1

Children 12 years and older (Myoclonic Seizures):

  • Initial dose: 1000 mg/day (500 mg twice daily)
  • Titration: Increase by 1000 mg/day every 2 weeks
  • Target dose: 3000 mg/day 1

Administration Guidelines

  • For children weighing ≤20 kg: Use oral solution
  • For children weighing >20 kg: Can use either tablets or oral solution
  • Administer with or without food 1

Weight-Based Dosing Table

Patient Weight 20 mg/kg/day (BID dosing) 40 mg/kg/day (BID dosing) 60 mg/kg/day (BID dosing)
20.1 to 40 kg 500 mg/day (250 mg BID) 1000 mg/day (500 mg BID) 1500 mg/day (750 mg BID)
>40 kg 1000 mg/day (500 mg BID) 2000 mg/day (1000 mg BID) 3000 mg/day (1500 mg BID)

Special Considerations

Titration Speed

  • Consider slower titration in patients with history of behavioral problems or psychiatric disorders, as behavioral side effects occur in approximately 12-15% of patients 2
  • In children, doses above 20 mg/kg/day should be introduced with caution to avoid paradoxical effects 3

Prophylactic Use

  • For children receiving CAR T-cell therapy with CNS disease or history of seizures: 10 mg/kg (maximum 500 mg per dose) every 12 hours for 30 days 4

Pharmacokinetics in Children

  • Children have approximately 30-40% higher clearance of levetiracetam compared to adults
  • A daily maintenance dose equivalent to 130-140% of the usual adult dose on a weight-normalized basis is recommended 5

Side Effects to Monitor

  • Most common: Somnolence (7-15%), dysphoria, nervousness 6
  • Behavioral side effects are more common in children with intellectual disability or psychiatric history 2, 3
  • Paradoxical effect (seizure worsening) may occur in 43% of children, particularly in those with mental retardation and on higher doses 3

Important Precautions

  • Warning: A paradoxical increase in seizures can occur, particularly in mentally retarded patients during the first 2 months of treatment 3
  • To minimize risk of paradoxical effects, consider:
    1. Lower initial dose (10 mg/kg/day)
    2. Slower dose escalation than manufacturer recommendations
    3. Extra caution when exceeding 20 mg/kg/day 3

Levetiracetam is generally well-tolerated and effective for a wide range of epileptic seizures in children, with studies showing 64.8% of patients becoming seizure-free and 83% achieving at least 50% seizure reduction 6.

References

Guideline

Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.